KRAS signaling induces the expression of immune regulatory factors and inflammatory cytokines in tumor cells, and subsequently recruits neutrophils and myeloid-derived suppressor cells (MDSC) to form an immunosuppressive tumor microenvironment (41). Here, KRAS is linked to neoplasm.